0001493152-23-034536.txt : 20230928 0001493152-23-034536.hdr.sgml : 20230928 20230928112722 ACCESSION NUMBER: 0001493152-23-034536 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230928 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230928 DATE AS OF CHANGE: 20230928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sharps Technology Inc. CENTRAL INDEX KEY: 0001737995 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 823751728 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41355 FILM NUMBER: 231287539 BUSINESS ADDRESS: STREET 1: 105 MAXESS ROAD STREET 2: STE. 124 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: (631) 574 -4436 MAIL ADDRESS: STREET 1: 105 MAXESS ROAD STREET 2: STE. 124 CITY: MELVILLE STATE: NY ZIP: 11747 8-K 1 form8-k.htm
0001737995 false 0001737995 2023-09-28 2023-09-28 0001737995 STSS:CommonStock0.0001ParValueMember 2023-09-28 2023-09-28 0001737995 STSS:CommonStockPurchaseWarrantsMember 2023-09-28 2023-09-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): September 28, 2023

 

Sharps Technology, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Nevada

(State or Other Jurisdiction of Incorporation)

 

001-41355   82-3751728

(Commission
File Number)

  

(IRS Employer
Identification No.)

 

 

 

105 Maxess Road, Melville, New York 11747

(Address of Principal Executive Offices)

 

 

 

(631) 574 -4436

(Registrant’s Telephone Number, Including Area Code)

 

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value   STSS   NASDAQ Capital Market
Common Stock Purchase Warrants   STSSW   NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 7.01 Regulation FD Disclosure

 

On September 28, 2023, Sharps Technology, Inc. (the “Company”) issued a press release. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference.

 

Exhibits 9.01 Financial Statements and Exhibits

 

Exhibit No.   Description
99.1   Press Release dated September 28, 2023
104   Cover Page Interactive Data File (embedded with the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 28, 2023

 

SHARPS TECHNOLOGY, INC.  
   
/s/ Robert Hayes  
Robert Hayes  
Chief Executive Officer  

 

 

 EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals

 

Transformative acquisition and purchase order enables Sharps to commercialize its innovative copolymer prefillable syringe systems to the healthcare market

 

Company has a capitalization strategy through debt that has resulted in a signed term sheet with a leading middle-market lender for up to $75 Million

 

NEW YORK, September 28, 2023 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (the “Company”) (NASDAQ: “STSS” and “STSSW”), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, issues a shareholder update from Robert Hayes, the Company’s Chief Executive Officer.

 

Dear Fellow Shareholders:

 

I am pleased to update you on Sharps’ recently signed Asset Purchase Agreement to acquire the InjectEZ facility , a specialty prefillable syringe manufacturing facility, and the associated $400 Million 10-year purchase agreement with Nephron Pharmaceuticals. This is a transformative, strategic set of events for Sharps and our shareholders, and I hope you share the enthusiasm I have for our future. I remain committed to the vision I had upon signing the partnership with Nephron and will stay the course through the Company’s transition to commercialization in early 2024. The signed agreements with Nephron advance the manufacturing and research partnership that we announced in November 2022, and reinforce our commitment to product innovation, advanced manufacturing, and commercialization. In this letter, I will provide key highlights about the Company’s vision, the proposed transaction, and the Company’s ongoing operations.

 

Strategic Partnership with Nephron Continues:

 

Our relationship with Nephron has strengthened since the signing of the initial agreement last year. Through the successful completion of the Asset Purchase Agreement and the 10-year purchase agreement, we will have a full partnership that will provide a strong baseline of revenue for Sharps for many years, supported by the $400 Million commitment from Nephron for the period. With full control of the InjectEZ facility through this transaction and the capacity from our wholly owned manufacturing facility in Hungary, Sharps will have the ability to supply Nephron with their prefilled syringe needs and also commercialize our smart safety syringe products to the broader healthcare syringe market. The agreement will leverage synergies from both companies and enable Sharps to commercially enter the prefilled syringe landscape with strength and ahead of plan.

 

 
 

 

Long-Term Revenue Stability and Growth:

 

A key component of the InjectEZ acquisition is the 10-year purchase agreement with Nephron and their commitment for minimum orders of more than $400 Million over the period. Nephron has committed to purchasing 10mL and 50mL prefillable copolymer syringes, with initial product delivery scheduled for the first quarter of 2024 and revenue for the first twelve months totaling approximately $30 Million. Subsequent shipments will continue until at least December of 2033 with minimum annual revenue of approximately $45 Million per year. In addition to the purchase agreement, Sharps will benefit from supplying Nephron because of their valued brand in the healthcare industry and leadership in areas such as 503B outsourcing, respiratory medicine, diagnostic kits, and specialty drug delivery solutions. As a company that is transitioning from research and development to commercialization, this is a significant development that will have a meaningful impact on Sharps’ revenue and profitability. We anticipate Nephron’s start-up volume to be approximately 60% of our initial planned manufacturing capacity, which will provide Sharps with the ability to fully service Nephron’s needs and to also sign purchase orders for our products from other companies in the healthcare market. Looking ahead, our team has begun working on expansion at the InjectEZ operation to provide for the additional planned capacity needed to service strategic customers in the branded and specialty Pharma space. Through this transformation and growth, we are committed to producing innovative drug delivery solutions for the healthcare sector, including smaller specialty configurations for biotech, ophthalmology, and cosmetic medicine.

 

Strength Through Acquiring InjectEZ:

 

Owning and operating the InjectEZ manufacturing facility will be a gamechanger for Sharps. Located on Nephron’s campus in West Columbia, South Carolina, the InjectEZ facility is a state-of-the-art manufacturing facility and one of the only fully dedicated specialized copolymer pre-filled syringe manufacturing plants in North America. The operation has fully automated pre-fillable syringe system manufacturing capabilities that include ISO cleanrooms for all key areas including injection molding, high speed automated assembly, and specialty packaging that include the use of Husky molding machines and Hahn automation. Looking ahead, our team has begun planning for expansion at InjectEZ to provide for additional capacity and expand our ability to service customers outside of Nephron. We have plans for expansion that will double our capacity from the current 45 Million to 90 Million units per year and expand the range of products to include specialty 0.5mL and 1.0mL formats and custom configurations.

 

 
 

 

Financing Strategy:

 

Our capitalization strategy for the InjectEZ transaction will use debt and preferred stock financing, while seeking to limit dilutive financings to fund working capital needs. As stated in the press release on September 28, 2023, we have worked through a multi-month financing process that has resulted in a signed term sheet with a leading middle-market lender for up to $75 Million in debt financing. Proceeds from the financing will be used for the acquisition of InjectEZ, non-dilutive working capital, and facility enhancements. Through the recent $5.6 Million raise, we are in a comfortable position with the working capital needed on hand as we work to close the debt financing. We are working through this process with diligence and will provide updates as developments advance. We have also reached an agreement with Nephron’s Bill and Lou Kennedy to let Sharps begin critical work on the facility and start up product development activities prior to closing the deal. This will allow for timely activities to be completed as soon as possible, per the agreed upon schedule. We will use part of the $5.6 Million raise to complete several of these milestones.

 

Increasing Capacity for a Growing Prefillable Syringe Market:

 

Current capacity levels at InjectEZ will fully support orders from Nephron, as well as our current projections for additional business from the open healthcare market for 2024 through 2026. We have design plans in place to double our capacity from 45 Million to 90 Million units per year, which we are forecasting to be in place in late 2026. The additional capacity will be used to serve our core business focus within the 503B and pharmaceutical segments of the healthcare industry, including specialty small volume pieces, infusion pumps, and novel drug delivery systems. Market research is forecasting for significant growth within the prefillable syringe segment, with product demand outstripping supply for the foreseeable future. The prefilled syringe market is a niche sub-industry within the healthcare sector that is growing faster than GDP, specifically within the copolymer segment of the market that Sharps will serve. We are excited for the opportunities for Sharps within this segment, as prefillable syringe capacity is at a premium due to the global lack of capacity, increasing demand, and technical challenges in production that our team has a wealth of experience in.

 

Accelerating Operations in Europe:

 

Operations at our wholly owned facility in Hungary are moving forward and hitting milestones as planned. We continue to manufacture and export our patented line of ultra-low waste, smart safety disposable syringe products for commercial use. In the first half of 2024, Sharps will introduce the Sologard Locking Plus syringe, a specialty FDA and WHO approved syringe system that will be offered in 3mL to 10mL barrel volumes. The team is also working to advance the facility to manufacture new product configurations and have identified opportunities for specialized size and technology options for our segment of the market. The facility has sufficient capacity for our growing needs and will be vital in supporting our efforts at the InjectEZ facility as we begin to execute on commercialization. While we remain committed to developing and commercializing disposable smart safety syringe technologies for the healthcare market, the opportunity to accelerate our prefillable syringe strategy, with support from the Hungary facility, will take priority in the near term to support our partnership with Nephron.

 

 
 

 

Conclusion:

 

We are at a pivotal time in our Company’s history and the recent transactions position Sharps for exciting commercial growth. I would like to thank Bill and Lou Kennedy at Nephron for their continued support and shared commitment to bringing our specialized products to the market. We look forward to providing updates as we move ahead with our plans. I want to give my sincere thanks to our shareholders for their continued support of Sharps Technology.

 

About Sharps Technology:

 

Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company’s product lines focus on providing ultra-low waste capabilities, that incorporate syringe technologies that use both passive and active safety features. Sharps also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The Company has a manufacturing facility in Hungary and has partnered with Nephron Pharmaceuticals to expand its manufacturing capacity in the U.S. For additional information, please visit www.sharpstechnology.com.

 

Forward-Looking Statements:

 

This press release contains “forward-looking statements”. Forward-looking statements reflect our current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,”“poised” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity, and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy, and other future conditions. Because forward–looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to raise capital to fund continuing operations; our ability to protect our intellectual property rights; the impact of any infringement actions or other litigation brought against us; competition from other providers and products; our ability to develop and commercialize products and services; changes in government regulation; our ability to complete capital raising transactions; and other factors relating to our industry, our operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance, or achievements. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.

 

Investor Relations:

 

US Investor Relations:    
     
Adam Holdsworth, Managing Director   Craig Brelsford, Specialist
TraDigital IR   RedChip Companies Inc.
adam@tradigitalir.com   craig@redchip.com

 

 

 EX-101.SCH 3 stss-20230928.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 stss-20230928_def.xml XBRL DEFINITION FILE EX-101.LAB 5 stss-20230928_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, $0.0001 par value Common Stock Purchase Warrants Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 stss-20230928_pre.xml XBRL PRESENTATION FILE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Sep. 28, 2023
Document Type 8-K
Amendment Flag false
Document Period End Date Sep. 28, 2023
Entity File Number 001-41355
Entity Registrant Name Sharps Technology, Inc.
Entity Central Index Key 0001737995
Entity Tax Identification Number 82-3751728
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 105 Maxess Road
Entity Address, City or Town Melville
Entity Address, State or Province NY
Entity Address, Postal Zip Code 11747
City Area Code 631
Local Phone Number 574 -4436
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock, $0.0001 par value  
Title of 12(b) Security Common Stock, $0.0001 par value
Trading Symbol STSS
Security Exchange Name NASDAQ
Common Stock Purchase Warrants  
Title of 12(b) Security Common Stock Purchase Warrants
Trading Symbol STSSW
Security Exchange Name NASDAQ
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001737995 2023-09-28 2023-09-28 0001737995 STSS:CommonStock0.0001ParValueMember 2023-09-28 2023-09-28 0001737995 STSS:CommonStockPurchaseWarrantsMember 2023-09-28 2023-09-28 iso4217:USD shares iso4217:USD shares 0001737995 false 8-K 2023-09-28 Sharps Technology, Inc. NV 001-41355 82-3751728 105 Maxess Road Melville NY 11747 631 574 -4436 false false false false Common Stock, $0.0001 par value STSS NASDAQ Common Stock Purchase Warrants STSSW NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( &I;/%<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !J6SQ78]=J\N\ K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M3L,P#(=?!>7>NG\$@ZCK!<0))"0F@;A%CK=%:]HH,6KW]J1AZX3@ 3C&_N7S M9\D-.HF#IQ<_./)L*%Q-MNN#1+<6>V8G 0+NR:J0QT0?F]O!6\7QZ7?@%![4 MCJ JBANPQ$HK5C #,[<01=MHE.A)\>!/>(T+WGWZ+L$T G5DJ>< 95Z":.>) M[CAU#5P ,XS)V_!=(+T04_5/;.J ."6G8);4.([Y6*=GU[1N9OK MJD>*OX*1?'2T%N?);_7]P^91M%51U5EQEU6WF_):5BM9KCYFUQ]^%V$[:+,U M_]CX+-@V\.LNVB]02P,$% @ :EL\5YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" !J6SQ7*3*^PK4$ "T$P & 'AL+W=O)&EBAUNEUHZ'\D,5478J4 M)?#-0LB8:MB5RX9*):-!'A1'#=>V.XV8\L0:]O-C4SGLBTQ'/&%32506QU1N M;U@DU@/+L5X///%EJ,V!QK"?TB7SF/Z>3B7L-0J5@,KZ(5/Z?K'?G MMFV+^)G2(MX' T',D]TGW>P3<1#0[!P).7%M MM_DVO $$!89;8+BY7O.(WJWP,ZBU)K-MRJIP\/#>Q6<$HEE -%&5$1 $.<5] M1)=5%'C\@D:*(1RM@J-U6C*F3'(1D+LD(%# MDGL>,3+)XGEU[^ :MNUSBD\3VS)E984?_$ (';MT3OL4QE$02*;4^>L&^0+GD:]) M)5B-I&.WSQ[IQJ@\"1I@F <&[WP(!1A/N>4KN_@ MOOV>K2CP5(H53_SJ'.*:D[\QM'(6.+B9OT>;"J7A_OV'IT>[KD;1<;JM+L96 MS@<'M_6\A"-8A!U'P04Z30<#*:>!@UOY%^%#3J:A2+!Q4"/2[K;(1:O5[&!( MY4!P<"=_EEQKED!FXCA+]J:F*K%PH;II[I03P,&-VQ,1][GFR9(\0G]+3J-* M'EREEJ>T?@=WZJED%SZDA\$-MEMTP;J'2?)UL3A20%ROEJQT?0=WYO^0/2B5 M 5DM("Y;!^B6GN^>Y/EW,9-+4\\_04&'IME2FE3.]!I!+3.4K+1YM\;FS7,. M"\A$0#T%^:X8T2$C=QMM0&:R.%,\G_&Y960F+_T9M'@^6^[A)F[L32#PM M_)=S\HM]:18W)*62K&CT/B-[-E31/+U>JY3Z;&#!XZEB\S-PFNJ2XTJ[:S\C\'?:];\E+J>$BYL\5#PP M/>IMX[FH=)P: 6_F>1A).29'B M]G[8@62:20"#6^:92O,443DO<,'_VX#E%'%Q__]( ^)*[QNP[O+? I=CQL7' MP@G]APN8_GO&4,JYXN(#X ,-6//H<+0!&P?O8,S[K$=J)H0B$5N DGW9A)\,V04QIPY ;Y?"*%?=\R;GN)%W?!?4$L#!!0 ( M &I;/%?@]#J)J@( # , - >&POG2N?I\DS>'(%6O>F)IKCY3&*N:\:JNDJ2UG10-. M2B:+V2Q+%!.:;E:Z53OE&G(PK79K.J/)9E4:?;&D-!C\4J8X.3&YIELFQ=Z* M?BU30IZ#>0&&@Y'&$N>I\#6=@Z5Y#O \:,!RB*.$-A:,2<@0?O?#\CM@U!JO M"BDG@@L:#)M5S9SC5N^\TB_NC2\@,LA/Y]HSK"P[SQ?OZ,6AO_DD>V,+;J:O_MA)L5&_W(T5CQ[+/!I!R\@5M*3MPZ<;BV M_+"L?N*=&Z>I*W'.B_^ M5O+"@>Q;(9W0@W841<'UBZGWX1W;^\?A37R_ON E:Z5[FL UO"%:E4^K M'F!?AE47^3.<[GDV/=-\+J$+WO%B.ZBVVOJS1'V"5PS9]A\L3]PG]U>\TCQ/TRS# M=G2[C3+88ON69?"-1\.X@0>6!S+]V5[CW<8GY/4YP'KZVH1@E>*3B%6*[S4@ M\7T#CSR/=QO+ QY8%[#9@?SQ/#!3<9\TA:YBW+ 3C"-YCB$PB_$9S3)D=S+X MQ/N#G9(TS?,X EB<09IB")Q&',$8 <,2=/^/7CW/DK&]U1R^8^P^0E02P,$ M% @ :EL\5Y>*NQS $P( L !?3T\$MP>:4#M.*2V MBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YV MX$G1H2)8%II%R=.B':5_'B4?'D78FYJD6:>IK&HP=MX1PT$G53$WHI"/J:Q8;!E MK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7D(GP&LK\,S4-AB.G8RF2&]B]#V,YU#BG/]3 M(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&[O+H YMRR"9JZJ8IGJ,.>%,. M]D9/)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48Y0]02P,$ M% @ :EL\5R0>FZ*M ^ $ !H !X;"]?+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*] M:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8V MP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X! M4$L#!!0 ( &I;/%=ED'F2&0$ ,\# 3 6T-O;G1E;G1?5'EP97-= M+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5 MA4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0 M]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K M'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+* M&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>= M(\G=560C2&2FKW@ALO7L^T%.6X.^D&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( &I;/%&PO7BKL

JQ"(6,P$ "(" / " ;<0 !X;"]W;W)K8F]O:RYX M;6Q02P$"% ,4 " !J6SQ7)!Z;HJT #X 0 &@ @ $7 M$@ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !J6SQ7 M99!YDAD! #/ P $P @ '\$@ 6T-O;G1E;G1?5'EP97-= :+GAM;%!+!08 "0 ) #X" !&% ! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://sharpstechnology.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm stss-20230928.xsd stss-20230928_def.xml stss-20230928_lab.xml stss-20230928_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "STSS", "nsuri": "http://sharpstechnology.com/20230928", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "stss-20230928.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "stss-20230928_def.xml" ] }, "labelLink": { "local": [ "stss-20230928_lab.xml" ] }, "presentationLink": { "local": [ "stss-20230928_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 26 }, "report": { "R1": { "role": "http://sharpstechnology.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-09-28", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-28", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "STSS_CommonStock0.0001ParValueMember": { "xbrltype": "domainItemType", "nsuri": "http://sharpstechnology.com/20230928", "localname": "CommonStock0.0001ParValueMember", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, $0.0001 par value" } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "STSS_CommonStockPurchaseWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://sharpstechnology.com/20230928", "localname": "CommonStockPurchaseWarrantsMember", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock Purchase Warrants" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://sharpstechnology.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001493152-23-034536-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-034536-xbrl.zip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